A multi-strain probiotic formulation preserves intestinal epithelial and vascular barriers during enteropathogenic infection
These findings suggest that this new formulation of multi-strain probiotics protects against <i>Salmonella</i>-induced damage to both the IEB and GVB, supporting its potential as a therapeutic intervention for managing conditions associated with intestinal barrier dysfunction. Further research is warranted to elucidate the specific mechanisms of action and validate these results in human populations.
Authors
- A Naso
- Paola Brescia (ORCID: https://orcid.org/0000-0003-2388-6820)
- Alessandra Silvestri (ORCID: https://orcid.org/0000-0001-9179-8385)
- Michela Lizier (ORCID: https://orcid.org/0000-0002-3173-5793)
- María Rescigno (ORCID: https://orcid.org/0000-0002-6464-509X)
- Carmen Correale (ORCID: https://orcid.org/0000-0002-6950-2987)
- Giuseppe Penna (ORCID: https://orcid.org/0000-0003-3534-7090)
Institutions
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-07-25
- DOI
- https://doi.org/10.3389/fmicb.2025.1631322
- Citations
- 4
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 3.22